Q4 2025 · 13F-HR
Exome Asset Management LLCholdings as filed
Filed 2026-02-13 · accession 0001420506-26-000376
$209.1M
Reported value
60
Positions
2025-12-31
Period end
The Brief · Exome Asset Management LLC · Q4 2025
AI · grounded in 13F
Exome Asset Management LLC established a new position in WVE with an investment of $7.17M. The fund also opened new stakes in ELV for $6.03M and JAZZ for $4.5M. On the sell side, the fund closed its positions in ETNBGBP and APGE, reducing exposure by $4.02M and $3.75M respectively.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $17.1M | 8.19% | 58,122 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $10.9M | 5.19% | 305,568 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $10.0M | 4.79% | 98,182 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $9.2M | 4.41% | 116,515 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $8.4M | 4.03% | 7,852 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $7.9M | 3.79% | 124,749 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $7.2M | 3.43% | 421,488 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $6.3M | 3.01% | 124,391 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.2M | 2.95% | 80,723 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $6.0M | 2.88% | 17,191 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $5.3M | 2.52% | 28,362 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $4.5M | 2.15% | 26,494 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $4.3M | 2.04% | 18,650 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $4.0M | 1.93% | 158,622 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $3.8M | 1.84% | 17,628 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $3.7M | 1.79% | 7,685 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $3.7M | 1.78% | 136,942 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $3.7M | 1.77% | 46,743 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $3.6M | 1.72% | 6,358 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $3.6M | 1.70% | 31,471 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $3.4M | 1.64% | 222,308 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $3.4M | 1.64% | 34,289 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $3.4M | 1.63% | 135,849 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $3.4M | 1.63% | 89,052 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $3.3M | 1.59% | 50,147 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $3.3M | 1.58% | 49,758 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $3.2M | 1.52% | 745,305 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $3.1M | 1.50% | 91,148 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $3.1M | 1.48% | 401,743 | Common | SOLE |
| 89422G957 | TVTX | TRAVERE THERAPEUTICS INC | $2.9M | 1.36% | 74,700 | PUT | SOLE |
| 022307102 | ALMS | ALUMIS INC | $2.9M | 1.36% | 292,250 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $2.8M | 1.34% | 9,000 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $2.7M | 1.28% | 163,658 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $2.7M | 1.27% | 76,750 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $2.5M | 1.19% | 100,046 | Common | SOLE |
| 65343E207 | NXTC | NEXTCURE INC | $2.3M | 1.12% | 165,000 | Common | SOLE |
| 07782B104 | BLTE | BELITE BIO INC | $2.3M | 1.10% | 14,328 | Common | SOLE |
| 946784105 | WAY | WAYSTAR HLDG CORP | $2.3M | 1.08% | 68,969 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $2.2M | 1.04% | 648,532 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $2.2M | 1.04% | 295,541 | Common | SOLE |
| 005329107 | ADAG | ADAGENE INC | $2.0M | 0.96% | 1,060,221 | Common | SOLE |
| 44975P103 | NBP | NOVABRIDGE BIOSCIENCES | $2.0M | 0.95% | 499,587 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $1.9M | 0.92% | 5,835 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $1.8M | 0.85% | 758,203 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $1.8M | 0.84% | 64,845 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.4M | 0.67% | 451,699 | Common | SOLE |
| 254604951 | IRON | DISC MEDICINE INC | $1.3M | 0.61% | 16,000 | PUT | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $1.2M | 0.59% | 600,000 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $1.2M | 0.58% | 5,378 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $1.2M | 0.58% | 6,084 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.1M | 0.54% | 139,543 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.0M | 0.50% | 92,055 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $954,728 | 0.46% | 13,100 | Common | SOLE |
| 90400D958 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $809,600 | 0.39% | 35,200 | CALL | SOLE |
| 022307952 | ALMS | ALUMIS INC | $519,232 | 0.25% | 53,200 | PUT | SOLE |
| 01438T906 | ALDX | ALDEYRA THERAPEUTICS INC | $518,000 | 0.25% | 100,000 | CALL | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $480,751 | 0.23% | 14,194 | Common | SOLE |
| 74017N955 | PGEN | PRECIGEN INC | $418,000 | 0.20% | 100,000 | PUT | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $363,078 | 0.17% | 75,484 | Common | SOLE |
| 834203959 | SLNO | SOLENO THERAPEUTICS INC | $327,523 | 0.16% | 7,100 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.